K Pharma,Inc. Logo

K Pharma,Inc.

4896 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木七丁目7番7号
Sector:
Health Care
Industry:
Pharmaceuticals

Description

K Pharma, Inc. is a pioneering Japanese biotechnology company focused on transforming healthcare through innovative applications of iPS cell technology. Established as a spin-off from the Keio University School of Medicine, the company leverages groundbreaking research from esteemed professors in physiology and orthopedic surgery. K Pharma specializes in two main areas: iPS drug discovery, utilizing disease-specific iPS cells to develop targeted treatments, and regenerative medicine, aimed at creating therapies for spinal cord injuries and cerebral infarctions. With a mission to bring hope to patients worldwide, K Pharma is committed to advancing medical science and improving patient outcomes through its cutting-edge research and development initiatives.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-28 02:01
Inside Information Statement
臨時報告書
Japanese 24.2 KB
2025-03-28 02:00
Internal Control over Financial Reporting
内部統制報告書-第8期(2024/01/01-2024/12/31)
Japanese 22.4 KB
2025-03-28 02:00
Annual Report
有価証券報告書-第8期(2024/01/01-2024/12/31)
Japanese 1.5 MB
2025-03-28 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-08-14 08:00
Regulatory News Service
確認書
Japanese 8.9 KB
2024-08-14 08:00
Interim Report
半期報告書-第8期(2024/01/01-2024/12/31)
Japanese 182.0 KB
2024-05-14 02:00
Quarterly Report
四半期報告書-第8期第1四半期(2024/01/01-2024/03/31)
Japanese 136.5 KB
2024-05-14 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-29 02:30
Inside Information Statement
臨時報告書
Japanese 22.6 KB
2024-03-28 07:01
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-28 07:00
Internal Control over Financial Reporting
内部統制報告書-第7期(2023/01/01-2023/12/31)
Japanese 22.4 KB
2024-03-28 07:00
Annual Report
有価証券報告書-第7期(2023/01/01-2023/12/31)
Japanese 1.5 MB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
D.Western Therapeutics Institute, Inc. Logo D.Western Therapeutics Institute, Inc. Japan 4576
EARNZ PLC Logo EARNZ PLC United Kingdom EARN
Eevia Health Plc Logo Eevia Health Plc Finland EEVIA
Egetis Therapeutics Logo Egetis Therapeutics Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo EIKEN CHEMICAL CO.,LTD. Japan 4549
Eisai Co., Ltd. Logo Eisai Co., Ltd. Japan 4523
ELARIS AG Logo ELARIS AG Germany ELS
Enervit Logo Enervit Italy ENV
Enorama Pharma AB Logo Enorama Pharma AB Sweden ERMA
Enzymatica AB Logo Enzymatica AB Sweden ENZY